Cardurion Pharmaceuticals Licenses Clinical Stage Heart Failure Candidate from Astellas
Company expanding pipeline of novel treatments for cardiovascular disease CAMBRIDGE, MASS. – [April 16, 2018] – Cardurion Pharmaceuticals, a biotechnology company focused on the development of [...]